搜索临床试验以:Complement C1 Inhibitor Protein
总计11020个结果
-
Alimentiv Inc.Alimentiv Translational Research Consortium终止
-
Universitätsklinikum Hamburg-EppendorfGerman Federal Ministry of Education and Research; University Hospital Heidelberg招聘中
-
IDEAYA Biosciences招聘中
-
Karolinska InstitutetUniversity of Copenhagen; Norwegian University of Science and Technology; University of Oulu; Reykjavik...完全的
-
Kami Maddocks, MD主动,不招人复发性小淋巴细胞淋巴瘤 | 幼淋巴细胞白血病 | 难治性/复发性慢性淋巴细胞白血病美国
-
Uma Borate招聘中复发性急性髓性白血病 | 难治性急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | 伴有 KMT2A 重排的急性髓性白血病 | NPM1突变的急性髓性白血病美国
-
Incyte Corporation终止
-
Hoffmann-La Roche完全的局部晚期实体瘤 | 转移性实体瘤美国, 大韩民国
-
University of BernUniversity of Zurich; Swiss National Science Foundation; Centre Hospitalier Universitaire Vaudois 和其他合作者尚未招聘
-
University Medical Center GoettingenLudwig-Maximilians - University of Munich; University of Leipzig; University Hospital Heidelberg; Technical University of Munich 和其他合作者招聘中
-
LaNova Medicines Zhejiang Co., Ltd.尚未招聘局部晚期或转移性 GC 和 GCJ 腺癌
-
Changi General Hospital完全的
-
Vanderson Geraldo Rocha终止
-
Shanghai Ninth People's Hospital Affiliated to...招聘中
-
Shenzhen People's HospitalInnovent Biopharmaceutical Co., Ltd.主动,不招人
-
New Mexico Cancer Care AllianceWyeth is now a wholly owned subsidiary of Pfizer终止
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.未知
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline完全的不可切除的黑色素瘤 | IV 期黑色素瘤 | III期黑色素瘤 | BRAF 突变型黑色素瘤美国
-
Hannover Medical School完全的